Study: Health Benefits of Curcumin with Piperine

A study by C. Pan et al titled “Curcumin-piperine supplementation modulates inflammation, oxidative stress, and cardiometabolic risk: a systematic review of randomized controlled trials” published on 18 May 2026 highlights some of the already known health benefits.

The paper is 12 pages, with the main text at about 10 pages. The remaining are acknowledgements and references.

Curcumin is known for its anti-inflammatory and antioxidant qualities. However, its

…clinical translation has been hindered by its poor oral bioavailability, due to low absorption and rapid metabolism, despite its promising pharmacological profile. By preventing glucuronidation and enhancing intestinal absorption, co-administration of piperine, an alkaloid derived from black pepper, increases curcumin bioavailability and amplifies its therapeutic potential.

The systematic review is comprised of 19 randomized control trials (RCTs) with a cumulative sample size of 8 to 117 participants ranging from 8 to 80 years of age.

The intervention lasted 1 to 12 weeks, but it usually lasted 8 to 12 weeks. The curcumin doses ranged from 500 to 1,500 mg/day, and piperine was co-administered at 5 to 15 mg/day. The trials mostly used a double-masked, placebo-controlled design and were conducted in several countries.

The majority of RCTs reported significant reductions in circulating inflammatory biomarkers, such as hs-CRP and IL-6.

When compared to a placebo, curcumin-piperine supplementation dramatically decreased hs-CRP and IL-6 concentrations in individuals with MetS and NAFLD. Similar anti-inflammatory benefits were observed in those with type 2 diabetes, where improvements in glycemic management and insulin resistance indices coincided with drops in IL-6 and CRP.

The benefits regarding inflammation seem to be more effective in dealing with chronic subclinical inflammation as opposed to reducing acute inflammatory reactions.

Regarding metabolic and glycemic regulation, improvements were reported after a “brief intervention” of 8–12 weeks.

Furthermore, both metabolic and post-stroke populations showed decreases in BMI and WC, indicating positive effects on central adiposity, a major predictor of insulin resistance and cardiometabolic risk. … At the same time, curcumin reduces cytokines such as TNF-α and IL-6, which affect insulin sensitivity in muscle, adipose tissue, and the liver, thereby attenuating inflammation-mediated interference with insulin receptor signaling. By boosting systemic curcumin exposure and enabling adequate tissue concentrations to alter various signaling pathways properly, piperine co-administration amplifies these effects. The observed decreases in BMI and WC suggest additional benefits for adipose tissue function.

As for cardiovascular biomarkers, “creatine kinase–myocardial band (CK-MB), AST, and ALT, were consistently reduced by curcumin–piperine supplementation in surgical and post-ischemic cardiovascular settings”.

These biochemical alterations point to a reduction in cardiomyocyte damage and possible defence against ischemia–reperfusion injury, a leading cause of morbidity after heart surgery and AMI. … At the same time, curcumin’s anti-inflammatory properties, mainly achieved by blocking NF-κB activation and the release of downstream cytokines (such as IL-6 and TNF-α), prevent inflammation-induced myocardial fibrosis and apoptosis.

In short, even though the studies reviewed are all short-term, it is apparent that curcumin and piperine have anti-inflammatory, antioxidant, metabolic, and potential cardioprotective effects. It is also safe, with only mild nausea and abdominal discomfort being reported.

---

Be sure to subscribe to our mailing list so you get each new Opinyun that comes out!

---